Zomedica Corp.
ZOMDF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001684144
No open-market purchases or sales by Zomedica Corp. insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $9.50K in total; no superinvestor holds it.
Holders of 5% or more of ZOMDF
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Zomedica Corp., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Zomedica Corp. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
3 Schedule 13D and 13G filings on Zomedica Corp., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 16, 2021 | Rowe Jeffrey M | 13G/AOld format | – | – | – | SEC |
| Jan 29, 2021 | Intracoastal Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Jan 5, 2021 | Sabby Management, LLC | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Zomedica Corp. shares.
No Form 144 notices for Zomedica Corp. are on file.